Abstract
No abstract available.
- Title
- Cosibelimab in advanced cutaneous squamous cell carcinoma (CSCC): Longer-term efficacy and safety results from pivotal study
- Authors
- E Muñoz-Couselo (Author) - Vall d'Hebron Institute of OncologyH Montaudie (Author) - Centre Hospitalier Universitaire de NiceM A Berciano Guerrero - Instituto de Investigación Biomédica de MálagaM D C Alamo De La Gala - Hospital Universitario Virgen MacarenaJ Charles (Author) - Centre Hospitalier Universitaire de GrenobleG Quereux - Centre Hospitalier Universitaire de NantesC Nardin - Centre Hospitalier Universitaire de BesançonR Yaya Tur - Fundación Instituto Valenciano de OncologíaS Dalle - Hospices Civils de LyonM Beylot-Barry - Hôpital Saint-AndréR Ladwa (Author) - Princess Alexandra HospitalD Brungs (Author) - Cancer Care Associates (Australia, Wollongong)D Harris (Author) - Christchurch HospitalHong Shue - University of the Sunshine Coast, Queensland, UniSC Clinical Trials CentreA Tazbirkova (Author) - Pindara Private Hospital (Australia, Benowa)S J Fourie - ABJ Wilgers Oncology Centre (South Africa, Pretoria)D R Malan - Phoenix Pharma (South Africa, Port Elizabeth)J Oliviero (Author) - Checkpoint Therapeutics (Waltham, United States)P Clingan (Author) - Cancer Care Associates (Australia, Wollongong)
- Publication details
- Annals of Oncology, Vol.35(S2), pp.S745-S746
- Conference details
- European Society for Medical Oncology (ESMO) Congress, 2024 (Barcelona, Spain, 13-Sep-2024 - 17-Sep-2024)
- Publisher
- Elsevier BV
- Date published
- 2024
- DOI
- 10.1016/j.annonc.2024.08.2139
- ISSN
- 1569-8041
- Organisation Unit
- UniSC Clinical Trials Centre
- Language
- English
- Record Identifier
- 991066295602621
- Output Type
- Abstract